Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > mdjbrown, I checked the couch for any spare loose change and
View:
Post by subaru1i on Nov 20, 2023 2:22pm

mdjbrown, I checked the couch for any spare loose change and

here's why.   Pidduck showed a great deal of confidence in this recent conference call to disclose that they and their pharma partner are waiting for FDA approval for a generic version of Epidiolex.  He then drops a clue big enough to figure it out quite easily w.r.t. to one of Brazil's largest generic makers having recently completed an acquisition....late September closing a deal by Eurofarm puts them as the strongest candidate.  Eurofarm covering all of South America as well as activity in the U.S. and Europe as a generic drug maker.  It doesn't take long to connect the dots that for South America, Brazil, ANVISA pending approval that it too is probably for a generic version of Epidiolex as well.   

In summary, based on those disclosures made during the last CC I personally take it as a strong level of confidence from Pidduck AND therefore we are in the zone of MAJOR NEWS PENDING!!!
Comment by okgonow on Nov 21, 2023 9:01am
the only problem with Connecting dots and tea leaf reading is that if you are off by 1 degree it all goes to POT (pun intended) been there seen it before. and alot of people get dissapointed especially in the micro small cap market. either they have something or they dont and we will trade at .06 to .10 for years to come
Comment by subaru1i on Nov 21, 2023 10:04am
With all due respect to you as a person, the content of your post deserves the trash can because it's pure garbage not reflecting upon the CEO's comments of pending FDA approval for generic form of Epidiolex that is broad spectrum based and from hybrid plants.   
Comment by okgonow on Nov 21, 2023 10:28am
the market seems to be agreeing with me ask at .065 with the bid at .06
Comment by subaru1i on Nov 21, 2023 11:21am
Good for you but my foundations are based on the science and the facts presented to date.   Maybe you should switch posting handles.  
Comment by okgonow on Nov 21, 2023 2:05pm
well my friend if your foundations were based on science and fact then tothers would see what you see and we would not be trading at .06 its your interpretations i have an issue with . You are interpreting things said by the ceo in the most positive way eg; the partner that LABS has under NDA must be a major player according to you ....i agree that they exist but they will only be a partner if and ...more  
Comment by subaru1 on Nov 21, 2023 12:40pm
Well,Okgonow, some guys here doesn't like to talk about the market, if you don't think like them you are a looser, i did the same projections based on the revenue and the growth of Labs but  someone said that i am a liar, reality is there we hit the $0,06 and with the tax lost season coming who knows where this will stop.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities